Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Small Cap

Small Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Initiation
  • Movers
  • News
  • Penny Stocks
  • Price Target
  • Small Cap
  • Trading Ideas

This COVID-19 Shot Stock Could Have Eye Disease Gene Therapy As Significant Driver, Mizuho Analyst Says

By Vandana Singh
August 23, 9:08 AM
Mizuho initiated coverage on Ocugen Inc (NASDAQ:OCGN) with a Buy rating and a price target of $5, reflecting an upside of almost…

OCGN

Read More
2 minute read
  • News
  • Small Cap

Immunome Announces Publication In Clinical & Translational Immunology Highlighting B Cell Repertoires In Patients with Breast Cancer

By Benzinga Newsdesk
August 23, 9:03 AM
The study demonstrates the importance of tumor and lymph node-derived B cells for the discovery of antibodies directed at potentially novel targets The study results provide a framework for understanding the evolution

IMNM

Read More
1 minute read
  • Analyst Ratings
  • Markets
  • News
  • Pre-Market Outlook
  • Price Target
  • Small Cap

AMC Entertainment Price Target Cut By This Analyst, Plus DA Davidson Predicts $318 For Estée Lauder

By Lisa Levin
August 23, 8:48 AM
DA Davidson cut the price target for The Estée Lauder Companies Inc. (NYSE: EL) from $342 to $318. Estée Lauder shares fell 0.4% to $264.29 in pre-market trading.

AERI

Read More
2 minute read
  • News
  • Small Cap

DIRTT Announces Temporary Suspension Of Operations At Rock Hill, SC Facility; Shifts To Savannah, GA and Calgary, AB Facility

By Benzinga Newsdesk
August 23, 8:17 AM
CALGARY, Alberta, Aug. 23, 2022 (GLOBE NEWSWIRE) -- DIRTT (or the "Company") (NASDAQ:DRTT, TSX:DRT) announced today the suspension of operations at its manufacturing facility in Rock Hill, South Carolina. WithCALGARY, Alberta, Aug.

DRTT

Read More
2 minute read
  • General
  • Health Care
  • Hedge Funds
  • M&A
  • News
  • Rumors
  • Small Cap

Owl Creek Urges Cano Health Board To Consider Potential Sale

By Vandana Singh
August 23, 8:14 AM
Owl Creek Asset Management L.P. sent a letter to Cano Health Inc (NYSE: CANO) board 

AGL

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers & Shakers
  • Small Cap

KalVista Shares Climb As Late-Stage Label Extension Study On Skin Disorder Candidate Kicks-off

By Ragothaman Srinivasan
August 23, 8:10 AM
KalVista Pharmaceuticals (NASDAQ: KALV) has initiated the KONFIDENT-S open label extension (OLE) study for its ongoing Phase 3 study of sebetralstat for the on-demand treatment of hereditary angioedema (HAE) attacks.

KALV

Read More
1 minute read
  • Markets
  • Media
  • News
  • Small Cap
  • Trading Ideas

Jim Cramer Is Staying Away From This Stock, Says It’s The ‘Best One Of A Bad Neighborhood’

By Priya Nigam
August 23, 8:06 AM
On CNBC’s "Mad Money Lightning Round," Jim Cramer said ChargePoint Holdings, Inc.

CHPT

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • M&A
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Alcon Buys Aerie Pharma For $770M To Enhance Its Ophthalmic Pharma Portfolio

By Vandana Singh
August 23, 6:16 AM
Alcon AG (NYSE:ALC) has agreed to acquire Aerie Pharmaceuticals Inc (NASDAQ:AERI) for $15.25 per share, valuing Aerie at about $770 million. The…

AERI

Read More
3 minute read
  • Earnings
  • Eurozone
  • Futures
  • Global
  • Markets
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap

U.S. Stock Futures Edge Higher Following Monday’s Sell-Off, Crude Oil Rises

By Lisa Levin
August 23, 5:18 AM
Pre-open movers

AERI

Read More
1 minute read
  • Markets
  • Movers
  • News
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

Vipshop Holdings, Signify Health And Other Big Gainers From Monday

By Lisa Levin
August 23, 5:02 AM
U.S. stocks closed sharply lower with the Nasdaq Composite dropping more than 300 points on Monday. Here is the list of some big stocks moving higher in the previous session.

AKLI

Posts pagination

Previous 1 … 977 978 979 … 1,074 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service